C07D 223/12
Nitrogen atoms not forming part of a nitro radical
C07D223/12 (Nitrogen atoms not forming part of a nitro radical) appears on 220 US grants and 170 published applications in this corpus.
Search patents in C07D- Granted patents
- 220
- Published applications
- 170
- Assignees
- 112
- Inventors
- 563
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 5 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 5 | 0 |
| 1995 | 1 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 5 | 0 |
| 1999 | 13 | 0 |
| 2000 | 11 | 0 |
| 2001 | 7 | 0 |
| 2002 | 8 | 12 |
| 2003 | 10 | 14 |
| 2004 | 6 | 13 |
| 2005 | 9 | 13 |
| 2006 | 11 | 10 |
| 2007 | 10 | 17 |
| 2008 | 12 | 13 |
| 2009 | 10 | 11 |
| 2010 | 6 | 13 |
| 2011 | 6 | 9 |
| 2012 | 3 | 2 |
| 2013 | 5 | 8 |
| 2014 | 4 | 3 |
| 2015 | 2 | 5 |
| 2016 | 4 | 2 |
| 2017 | 3 | 3 |
| 2018 | 1 | 5 |
| 2019 | 4 | 3 |
| 2020 | 3 | 2 |
| 2021 | 0 | 3 |
| 2022 | 1 | 3 |
| 2023 | 2 | 1 |
| 2024 | 0 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof4 Aug 2026US 12,698,259 B2Dana-Farber Cancer Institute, Inc.
- Inhibitors of influenza viral entry17 Oct 2023US 11,787,769 B2Chicago Biosolutions, Inc.
- Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection10 Jan 2023US 11,548,893 B2Arisan Therapeutics Inc.
- Biphenyl compound or salt thereof25 Oct 2022US 11,479,563 B2Taiho Pharmaceutical Co., Ltd.
- Histone deacetylase inhibitors1 Dec 2020US 10,851,058 B2Biomarin Pharmaceutical Inc.
- Lsd1 modulators23 Jul 2026US 2026/0209214 A1Recursion Pharmaceuticals, Inc.
- Cereblon e3 ligase binding compound, pharmaceutical composition containing same, and production method therefor25 Dec 2025US 2025/0388593 A1Mitsubishi Tanabe Pharma Corporation
- Heterocyclic compound7 Aug 2025US 2025/0250230 A1
- Fpr2 (formyl peptide receptor 2)receptor agonists and their use in the treatment of the autism spectrum disorder30 May 2024US 2024/0174617 A1Universita' Degli Studi Di Bari Aldo Moro
- Compositions and methods for treating neurodegenerative diseases and disorders14 Mar 2024US 2024/0083839 A1The Regents of the University of California
Most cited
By later US patents
- Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors60US 5,811,422 AThe DuPont Merck Pharmaceutical Company · 1998
- Diaminopropionic acid derivatives50US 6,331,640 B1Hoffmann-La Roche Inc. · 2001
- 2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity49US 4,533,739 AG. D. Searle & Co. · 1985
- Lactam-containing hydroxamic acids47US 5,672,598 AThe Procter & Gamble Company · 1997
- Diaminopropionic acid derivatives45US 6,803,384 B2Hoffmann-La Roche Inc. · 2004